ASCEND BY NTHRYS
Research Abroad Products

Medical Biochemistry Project Topics

Browse all focused areas across all project categories under this field.

Showing 169–180 of 200 project topics
Resistance Mutation Prediction and Monitoring Analytics Tool
SaaS platform that predicts acquired drug resistance mutations in cancer and monitors their emergence through cfDNA and ctDNA analysis, enabling proactive therapeutic switching. Prevents treatment failures in 30% of cases and supports precision oncology protocols, driving recurring subscriptions from oncology practices and hospital systems.
Oncology Medical Biochemistry Drug Discovery Click to view more details →
Bioavailability and Pharmacokinetic Optimization Workbench
Integrated software workbench that models drug physicochemical properties, absorption, distribution, metabolism, and excretion pathways specific to cancer therapeutics for lead optimization. Accelerates drug candidate optimization by 45% and reduces development costs by $5M per compound, monetized through perpetual licenses and research partnerships.
Oncology Medical Biochemistry Drug Discovery Click to view more details →
Hepatic Drug Metabolism Prediction Engine SaaS Platform
A cloud-based computational platform that predicts liver drug metabolism pathways and cytochrome P450 interactions before clinical trials. Reduces drug development timelines by 18-24 months and decreases late-stage failure rates, generating recurring subscription revenue from pharma companies.
Liver Biochemistry Drug Development Platforms Click to view more details →
Liver Toxicity Biomarker Detection High-Throughput Screening Kit
An automated laboratory kit that identifies hepatotoxic compounds using ALT, AST, and emerging biomarkers through parallel sample processing. Enables pharmaceutical companies to screen 10,000+ drug candidates monthly, accelerating compound selection and reducing research costs by 35%.
Liver Biochemistry Drug Development Platforms Click to view more details →
Real-Time Liver Function Monitoring IoT Device Platform
A wearable IoT device paired with mobile application that continuously monitors liver enzyme levels and bilirubin metabolism in clinical trial participants. Provides real-time safety data to contract research organizations (CROs) and pharmaceutical sponsors, enabling proactive adverse event management and trial retention.
Liver Biochemistry Drug Development Platforms Click to view more details →
Hepatic Clearance Pharmacokinetics Digital Twin Simulation Software
A machine learning platform that creates patient-specific digital twins to model individual liver clearance rates and drug dosing responses. Enables personalized medicine services and licensing opportunities for diagnostic companies seeking differentiated biomarker-driven dosing solutions.
Liver Biochemistry Drug Development Platforms Click to view more details →
Hepatic Enzyme Activity Laboratory Information Management System
A specialized LIMS designed for liver biochemistry assay tracking, data integration, and regulatory compliance documentation across preclinical and clinical phases. Streamlines laboratory operations, reduces manual errors by 40%, and accelerates FDA submission documentation packages.
Liver Biochemistry Drug Development Platforms Click to view more details →
Drug-Induced Liver Injury Prediction Analytics Dashboard
An advanced analytics dashboard aggregating historical DILI data, chemical structures, and metabolism patterns to predict hepatotoxicity risk in novel compounds. Supports go-no-go decision-making for development candidates and reduces clinical trial safety incidents by informing earlier stage termination.
Liver Biochemistry Drug Development Platforms Click to view more details →
Hepatic Transporter Interaction Screening Commercial Testing Service
A fee-for-service laboratory offering specialized assays for hepatic transporter substrates (OATP, MDR1, BCRP) interaction testing and DDI prediction. Generates recurring revenue by supporting drug-drug interaction (DDI) investigations for small biotech companies lacking in-house hepatology expertise.
Liver Biochemistry Drug Development Platforms Click to view more details →
Liver Fibrosis Biomarker Quantification Automated Assay Platform
An automated multiplex assay platform measuring non-invasive fibrosis markers (hyaluronic acid, P3NP, TIMP-1) to assess hepatic damage in drug safety trials. Enables CROs and pharmaceutical companies to monitor cumulative liver injury, opening new revenue streams in integrated safety monitoring services.
Liver Biochemistry Drug Development Platforms Click to view more details →
Hepatic Glucuronidation Pathway Enzyme Kinetics Database Portal
A proprietary online database and portal providing comprehensive UGT enzyme kinetic data, substrate specificity, and inhibition profiles for novel compounds. Monetizes through subscription access for medicinal chemists and DMPK teams, enabling faster structure-activity relationship (SAR) optimization.
Liver Biochemistry Drug Development Platforms Click to view more details →
Hepatic Steatosis Progression Monitoring Image Analysis Software
An AI-powered image analysis software that quantifies liver fat accumulation in MRI and ultrasound data to detect drug-induced fatty liver disease during toxicology studies. Provides objective, quantified endpoints for safety reporting and supports development of metabolic disease therapeutics through novel imaging biomarkers.
Liver Biochemistry Drug Development Platforms Click to view more details →